Independent DirectorMs. Robin Smith Hoke is a seasoned pharmaceutical and healthcare executive with a passion for linking commercial strategies with innovation to drive company growth and transformation. She is results-oriented and thrives on aligning and building productive and engaged management teams.
For the past 6 years, Ms. Hoke served as President and CEO of Leiters, an FDA-registered outsourcing facility under 503B of the DQSA. Under her leadership, Leiters experienced a growth rate exceeding 1200% and a successful sale to a private equity (PE) financial sponsor.
Prior, at Cardinal Health, her roles included Senior Vice President of Global Business Development and Strategic Initiatives, Generic Pharmaceuticals, and General Counsel for the pharmaceutical technologies & services business segment. She also held legal roles at Abbott Laboratories and was Partner in the business law firm of Kegler, Brown, Hill & Ritter, Co., L.P.A.
Ms. Hoke has served on several private and public boards, including Ricerca Biosciences, a PE-backed, pre-clinical CRO, and Camargo Pharmaceuticals, LLC., a global 505B2 specialty services company. Her public board experience includes Aeterna Zentaris and Oncobiologics. She currently serves on the board of AeroSafe Global, a strategic advisor to Leiters. She received her law degree from Thomas M. Cooley Law School, cum laude, and her undergraduate degrees from Michigan State University.